P35240

PTMD Annotation Information


※ Protein Information

Tag Content
UniProt Accession MERL_HUMAN; P35240;
Entrez ID 4771
GenBank Protein ID NM_000268.3; NM_016418.5; NM_181825.2; NM_181828.2; NM_181829.2; NM_181830.2; NM_181831.2; NM_181832.2; NM_181833.2;
GenBank Nucleotide ID NP_000259.1; NP_057502.2; NP_861546.1; NP_861966.1; NP_861967.1; NP_861968.1; NP_861969.1; NP_861970.1; NP_861971.1;
Protein Name Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomerlin) (Schwannomin)
Gene Name NF2; SCH
Organism Homo sapiens
NCBI Taxa ID 9606
Functional DescriptionProbable regulator of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway, a signaling pathway that plays a pivotal role in tumor suppression by restricting proliferation and promoting apoptosis. Along with WWC1 can synergistically induce the phosphorylation of LATS1 and LATS2 and can probably function in the regulation of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway. May act as a membrane stabilizing protein. May inhibit PI3 kinase by binding to AGAP2 and impairing its stimulating activity. Suppresses cell proliferation and tumorigenesis by inhibiting the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex.
Sequence
(Fasta)
MAGAIASRMS FSSLKRKQPK TFTVRIVTMD AEMEFNCEMK WKGKDLFDLV CRTLGLRETW 60
FFGLQYTIKD TVAWLKMDKK VLDHDVSKEE PVTFHFLAKF YPENAEEELV QEITQHLFFL 120
QVKKQILDEK IYCPPEASVL LASYAVQAKY GDYDPSVHKR GFLAQEELLP KRVINLYQMT 180
PEMWEERITA WYAEHRGRAR DEAEMEYLKI AQDLEMYGVN YFAIRNKKGT ELLLGVDALG 240
LHIYDPENRL TPKISFPWNE IRNISYSDKE FTIKPLDKKI DVFKFNSSKL RVNKLILQLC 300
IGNHDLFMRR RKADSLEVQQ MKAQAREEKA RKQMERQRLA REKQMREEAE RTRDELERRL 360
LQMKEEATMA NEALMRSEET ADLLAEKAQI TEEEAKLLAQ KAAEAEQEMQ RIKATAIRTE 420
EEKRLMEQKV LEAEVLALKM AEESERRAKE ADQLKQDLQE AREAERRAKQ KLLEIATKPT 480
YPPMNPIPAP LPPDIPSFNL IGDSLSFDFK DTDMKRLSME IEKEKVEYME KSKHLQEQLN 540
ELKTEIEALK LKERETALDI LHNENSDRGG SSKHNTIKKL TLQSAKSRVA FFEEL 596

※ PTM-Disease Association

NumPTMDiseaseCell TypeTypePTM SitePMID
1PhosphorylationColon cancer/carcinomaA24323642
[Reference]: in normal tissues the phosphorylated form of Merlin was found to be the predominant one, while in the tumor tissues the unphosphorylated form was found to be more pronounced
2Serine PhosphorylationMesotheliomaUS51818835652
[Reference]: In patient samples, merlin was truncated or phosphorylated on S518

※ Disease Cross-ref Annotation

DatabaseAnnotation
Cancer Gene Census
meningioma, acoustic neuroma, renal meningioma, acoustic neuroma neurofibromatosis type 2
CTD (Curated)
(count: 8)
(view all)
MESH:D002292 ; Carcinoma, Renal Cell
MESH:D008579 ; Meningioma
MESH:C537443 ; Meningioma, familial
MESH:D008654 ; Mesothelioma
MESH:C562839 ; Mesothelioma, Malignant
MESH:D016518 ; Neurofibromatosis 2
HGMD
(count: 351)
(view all)
CP045525; Neurofibromatosis 2; Complex rearrangements
CP045526; Neurofibromatosis 2; Complex rearrangements
CP005301; Neurofibromatosis 2; Complex rearrangements
CD077834; Neurofibromatosis 2; Small deletions
CD066383; Neurofibromatosis 2; Small deletions
CD004510; Neurofibromatosis 2; Small deletions
GWASdb
(count: 8)
(view all)
rs6006220; Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption); hypertension
rs2857641; Blood pressure (response to angiotensin-converting enzyme inhibitor); hypertension
rs2527335; Amyotrophic lateral sclerosis (sporadic); amyotrophic lateral sclerosis
rs2857648; Urinary metabolites; kidney disease
rs16987928; Urinary metabolites; kidney disease
rs2530678; Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption); hypertension

※ PTM Sites

PTM Modification Sites
Phosphorylation
(count: 15)
(view all)
10        GAIASRMSFSSLKRK     dbPAF
12        IASRMSFSSLKRKQP     dbPAF
13        ASRMSFSSLKRKQPK     dbPAF
177       PKRVINLYQMTPEMW     dbPAF
180       VINLYQMTPEMWEER     dbPAF
189       EMWEERITAWYAEHR     dbPAF
Acetylation
(count: 1)
279       TIKPLDKKIDVFKFN     PLMD
Ubiquitination
(count: 15)
(view all)
159       DYDPSVHKRGFLAQE     PLMD
171       AQEELLPKRVINLYQ     PLMD
253       PENRLTPKISFPWNE     PLMD
269       RNISYSDKEFTIKPL     PLMD
322       SLEVQQMKAQAREEK     PLMD
364       ERRLLQMKEEATMAN     PLMD
Sumoylation
(count: 2)
550       KTEIEALKLKERETA     PLMD
76        KDTVAWLKMDKKVLD     PLMD

※ Protein-Protein Interaction

NetworkInteraction
ABSource